This topic contains a solution. Click here to go to the answer

Author Question: With hydrocephalus: a. The brain loses the ability to reorganize b. The cerebral walls expand to ... (Read 53 times)

stock

  • Hero Member
  • *****
  • Posts: 573
With hydrocephalus:
 
  a. The brain loses the ability to reorganize
  b. The cerebral walls expand to nearly twice their normal size
  c. Cerebrospinal fluid accumulates, interfering with brain growth
  d. All of the above

Question 2

In contrast to chronic stress, short-term stress:
 
  a. Decreases the activity of neurons within the hypothalamus
  b. Does not alter the immune system
  c. Enhances the immune response
  d. Inactivates white blood cells



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

mcarey591

  • Sr. Member
  • ****
  • Posts: 365
Answer to Question 1

C

Answer to Question 2

C




stock

  • Member
  • Posts: 573
Reply 2 on: Jun 22, 2018
YES! Correct, THANKS for helping me on my review


sarah_brady415

  • Member
  • Posts: 328
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

In Eastern Europe and Russia, interferon is administered intranasally in varied doses for the common cold and influenza. It is claimed that this treatment can lower the risk of infection by as much as 60–70%.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

Did you know?

In 1886, William Bates reported on the discovery of a substance produced by the adrenal gland that turned out to be epinephrine (adrenaline). In 1904, this drug was first artificially synthesized by Friedrich Stolz.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library